BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 37886355)

  • 1. Dysregulated metal ion homeostasis underscores non-canonical function of CD8
    Khare K; Chattopadhyay P; Devi P; Mehta P; Raina A; Liu CSC; Tardalkar K; Joshi MG; Pandey R
    Front Med (Lausanne); 2023; 10():1282390. PubMed ID: 37886355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-cell multiomics revealed the dynamics of antigen presentation, immune response and T cell activation in the COVID-19 positive and recovered individuals.
    Chattopadhyay P; Khare K; Kumar M; Mishra P; Anand A; Maurya R; Gupta R; Sahni S; Gupta A; Wadhwa S; Yadav A; Devi P; Tardalkar K; Joshi M; Sethi T; Pandey R
    Front Immunol; 2022; 13():1034159. PubMed ID: 36532041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic Landscapes of Single-Cell Chromatin Accessibility and Transcriptomic Immune Profiles of T Cells in COVID-19 Patients.
    Li S; Wu B; Ling Y; Guo M; Qin B; Ren X; Wang C; Yang H; Chen L; Liao Y; Liu Y; Peng X; Xu C; Wang Z; Shen Y; Chen J; Liu L; Niu B; Zhu M; Liu L; Li F; Zhu T; Zhu Z; Zhou X; Lu H
    Front Immunol; 2021; 12():625881. PubMed ID: 33717140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the Levels of Peripheral CD3
    Aljabr W; Al-Amari A; Abbas B; Karkashan A; Alamri S; Alnamnakani M; Al-Qahtani A
    Microbiol Spectr; 2022 Feb; 10(1):e0084521. PubMed ID: 35196808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dissecting CD8+ T cell pathology of severe SARS-CoV-2 infection by single-cell immunoprofiling.
    Schreibing F; Hannani MT; Kim H; Nagai JS; Ticconi F; Fewings E; Bleckwehl T; Begemann M; Torow N; Kuppe C; Kurth I; Kranz J; Frank D; Anslinger TM; Ziegler P; Kraus T; Enczmann J; Balz V; Windhofer F; Balfanz P; Kurts C; Marx G; Marx N; Dreher M; Schneider RK; Saez-Rodriguez J; Costa I; Hayat S; Kramann R
    Front Immunol; 2022; 13():1066176. PubMed ID: 36591270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The unreversible reduced but persistent activated NK and CD8
    Qin L; Duan X; Dong JZ; Chang Y; Han Y; Li Y; Jiang W; Fan H; Hou X; Cao W; Zhu H; Li T
    Emerg Microbes Infect; 2023 Dec; 12(1):2208679. PubMed ID: 37102227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of Cytotoxic T Cells and Dysfunctional CD8 T Cells in Severe COVID-19 Patients.
    Gozzi-Silva SC; Oliveira LM; Alberca RW; Pereira NZ; Yoshikawa FS; Pietrobon AJ; Yendo TM; de Souza Andrade MM; Ramos YAL; Brito CA; Oliveira EA; Beserra DR; Orfali RL; Aoki V; Duarte AJDS; Sato MN
    Cells; 2022 Oct; 11(21):. PubMed ID: 36359755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD4
    Popescu I; Snyder ME; Iasella CJ; Hannan SJ; Koshy R; Burke R; Das A; Brown MJ; Lyons EJ; Lieber SC; Chen X; Sembrat JC; Bhatt P; Deng E; An X; Linstrum K; Kitsios G; Konstantinidis I; Saul M; Kass DJ; Alder JK; Chen BB; Lendermon EA; Kilaru S; Johnson B; Pilewski JM; Kiss JE; Wells AH; Morris A; McVerry BJ; McMahon DK; Triulzi DJ; Chen K; Sanchez PG; McDyer JF
    Am J Respir Crit Care Med; 2022 Jun; 205(12):1403-1418. PubMed ID: 35348444
    [No Abstract]   [Full Text] [Related]  

  • 9. Predominantly defective CD8
    Taus E; Shino MY; Ibarrondo FJ; Hausner MA; Hofmann C; Yang OO
    J Transl Med; 2023 Jun; 21(1):374. PubMed ID: 37291575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breadth and Durability of SARS-CoV-2-Specific T Cell Responses following Long-Term Recovery from COVID-19.
    Dang TTT; Anzurez A; Nakayama-Hosoya K; Miki S; Yamashita K; de Souza M; Matano T; Kawana-Tachikawa A
    Microbiol Spectr; 2023 Aug; 11(4):e0214323. PubMed ID: 37428088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrating single-cell sequencing data with GWAS summary statistics reveals CD16+monocytes and memory CD8+T cells involved in severe COVID-19.
    Ma Y; Qiu F; Deng C; Li J; Huang Y; Wu Z; Zhou Y; Zhang Y; Xiong Y; Yao Y; Zhong Y; Qu J; Su J
    Genome Med; 2022 Feb; 14(1):16. PubMed ID: 35172892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunodominant SARS-CoV-2-specific CD4
    Ning J; Wang Q; Chen Y; He T; Zhang F; Chen X; Shi L; Zhai A; Li B; Wu C
    J Med Virol; 2023 Apr; 95(4):e28743. PubMed ID: 37185843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Memory T Cells Discrepancies in COVID-19 Patients.
    Al Saihati HA; Hussein HAM; Thabet AA; Wardany AA; Mahmoud SY; Farrag ES; Mohamed TIA; Fathy SM; Elnosary ME; Sobhy A; Ahmed AE; El-Adly AM; El-Shenawy FS; Elsadek AA; Rayan A; Zahran ZAM; El-Badawy O; El-Naggar MGM; Afifi MM; Zahran AM
    Microorganisms; 2023 Nov; 11(11):. PubMed ID: 38004749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamic SARS-CoV-2-Specific Immunity in Critically Ill Patients With Hypertension.
    Zeng Q; Li YZ; Dong SY; Chen ZT; Gao XY; Zhang H; Huang G; Xu Y
    Front Immunol; 2020; 11():596684. PubMed ID: 33362779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T-cell recovery and evidence of persistent immune activation 12 months after severe COVID-19.
    Taeschler P; Adamo S; Deng Y; Cervia C; Zurbuchen Y; Chevrier S; Raeber ME; Hasler S; Bächli E; Rudiger A; Stüssi-Helbling M; Huber LC; Bodenmiller B; Boyman O; Nilsson J
    Allergy; 2022 Aug; 77(8):2468-2481. PubMed ID: 35567391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Role of Lymphocyte Subsets, PD-1, and FAS (CD95) in COVID-19 Cancer Patients.
    Kandeel EZ; Refaat L; Bayoumi A; Nooh HA; Hammad R; Khafagy M; Abdellateif MS
    Viral Immunol; 2022 Sep; 35(7):491-502. PubMed ID: 35930238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T cell immune response predicts survival in severely ill COVID-19 patients requiring venovenous extracorporeal membrane oxygenation support.
    Ulakcsai Z; Szabo L; Szabo Z; Karaszi E; Szabo T; Fazekas L; Vereb A; Kovacs NF; Nemeth D; Kovacs E; Nemeth E; Nagy G; Vago H; Merkely B
    Front Immunol; 2023; 14():1179620. PubMed ID: 37600824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunological Characteristics in Type 2 Diabetes Mellitus Among COVID-19 Patients.
    Han M; Ma K; Wang X; Yan W; Wang H; You J; Wang Q; Chen H; Guo W; Chen T; Ning Q; Luo X
    Front Endocrinol (Lausanne); 2021; 12():596518. PubMed ID: 33776910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamics of NK, CD8 and Tfh cell mediated the production of cytokines and antiviral antibodies in Chinese patients with moderate COVID-19.
    Yan L; Cai B; Li Y; Wang MJ; An YF; Deng R; Li DD; Wang LC; Xu H; Gao XD; Wang LL
    J Cell Mol Med; 2020 Dec; 24(24):14270-14279. PubMed ID: 33145962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longitudinal Dynamics of Cellular Responses in Recovered COVID-19 Patients.
    Cheng ML; Liu HY; Zhou C; Li RT; Zheng J; Qin YH; Yang N; Zhang Y; Huang JJ; Zhu Z; Meng QY; Wang GQ; Zhao H; Chen Y; Bai CQ; Qin CF; Li F
    Front Immunol; 2022; 13():911859. PubMed ID: 35663993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.